Journal: Neuroscience Bulletin
Article Title: Fibroblast Growth Factor 8 Suppresses Neurotoxic Astrocytes and Alleviates Neuropathic Pain via Spinal FGFR3 Signaling
doi: 10.1007/s12264-025-01533-x
Figure Lengend Snippet: SNI induces persistent microglial activation in the SDH. A , B Representative immunofluorescence images ( A ) and quantification ( B ) of IBA-1 staining in the ipsilateral SDH from day 1 to day 14 post-SNI. C , D Representative Western blot images ( C ) and quantification ( D ) of IBA-1 protein levels in the L2–L5 spinal cord segments from day 4 to day 14 post-SNI. E Representative skeletonized images of individual IBA-1⁺ microglia from sham and SNI mice. F , G Quantification of microglial morphology on days 4, 7, and 14 post-SNI, showing a significant increase in soma area ( F ) and a decrease in process length ( G ) compared to sham controls. H – J Sholl analysis demonstrates reduced microglial process complexity in SNI mice compared to sham controls. n = 9 slices. K qRT-PCR analysis of Tnf-α , Il-1α , and C1q in the ipsilateral SDH from sham and SNI mice on day 14 ( n = 5–6 mice). L qRT-PCR analysis of Tnf-α , Il-1α , and C1q in spinal cord tissue from SNI mice treated with FGF8 or vehicle on day 14 ( n = 6 per group). M Representative images of C3 and GFAP co-localization and quantification of C3 and GFAP in the SDH of control and FGFR3 shRNA mice following i.t. LPS administration. n = 9 slices ( B ), n = 8–11 cells ( F – J ) from 3 mice; n = 4–6 mice ( D , K , L ); n = 12-13 slices ( M ) from 3 mice. Statistics by two-way ANOVA followed by post hoc Holm-Sidak test ( B , D , F , G ). Scale bar: 25 μm ( A , E , M ). Statistics by two-way ANOVA ( H-I ), two-tailed Student’s t -test ( K , L ), and Mann-Whitney U test ( M ). * P < 0.05, ** P < 0.01. Data are presented as mean ± SEM.
Article Snippet: Recombinant FGF8 protein (0.5 μg or 1 μg in 5 μL PBS; R&D Systems, 423-F8-025/CF) was administered via intrathecal (i.t.) lumbar puncture between L5–L6 vertebrae under isoflurane anesthesia using a 31G needle-equipped Hamilton syringe (25 μL volume).
Techniques: Activation Assay, Immunofluorescence, Staining, Western Blot, Quantitative RT-PCR, Control, shRNA, Two Tailed Test, MANN-WHITNEY